| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ovarian Neoplasms | 10 | 2016 | 303 | 1.130 |
Why?
|
| DNA Transposable Elements | 6 | 2011 | 44 | 1.040 |
Why?
|
| Retroelements | 7 | 2010 | 12 | 0.860 |
Why?
|
| Gene Expression Profiling | 10 | 2016 | 600 | 0.570 |
Why?
|
| Evolution, Molecular | 7 | 2010 | 249 | 0.570 |
Why?
|
| Terminal Repeat Sequences | 4 | 2010 | 8 | 0.450 |
Why?
|
| Neoplastic Stem Cells | 2 | 2011 | 74 | 0.450 |
Why?
|
| Ovary | 2 | 2009 | 101 | 0.420 |
Why?
|
| Prostatic Neoplasms | 5 | 2023 | 794 | 0.410 |
Why?
|
| Repressor Proteins | 3 | 2019 | 226 | 0.410 |
Why?
|
| Drosophila melanogaster | 2 | 2004 | 168 | 0.400 |
Why?
|
| Open Reading Frames | 3 | 2007 | 73 | 0.390 |
Why?
|
| DNA-Binding Proteins | 4 | 2017 | 522 | 0.380 |
Why?
|
| Multipotent Stem Cells | 1 | 2009 | 16 | 0.370 |
Why?
|
| Chromatin | 2 | 2011 | 164 | 0.330 |
Why?
|
| Promoter Regions, Genetic | 3 | 2019 | 484 | 0.320 |
Why?
|
| Epithelial Cells | 2 | 2011 | 366 | 0.310 |
Why?
|
| Paired Box Transcription Factors | 1 | 2006 | 7 | 0.300 |
Why?
|
| Fallopian Tubes | 1 | 2006 | 16 | 0.300 |
Why?
|
| Transcription Factors | 5 | 2019 | 653 | 0.290 |
Why?
|
| Phylogeny | 9 | 2010 | 612 | 0.280 |
Why?
|
| Computational Biology | 3 | 2006 | 275 | 0.270 |
Why?
|
| Cell Line, Tumor | 12 | 2023 | 2128 | 0.270 |
Why?
|
| Gene Expression Regulation, Neoplastic | 8 | 2019 | 781 | 0.260 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2019 | 52 | 0.260 |
Why?
|
| Coat Protein Complex I | 1 | 2004 | 1 | 0.250 |
Why?
|
| COP-Coated Vesicles | 1 | 2004 | 1 | 0.250 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2004 | 52 | 0.250 |
Why?
|
| DNA Helicases | 1 | 2004 | 40 | 0.240 |
Why?
|
| Genome | 2 | 2007 | 117 | 0.240 |
Why?
|
| DNA Polymerase II | 1 | 2003 | 5 | 0.240 |
Why?
|
| Schizosaccharomyces | 1 | 2003 | 11 | 0.240 |
Why?
|
| Adenosine Triphosphatases | 1 | 2004 | 78 | 0.240 |
Why?
|
| Genome, Fungal | 1 | 2003 | 21 | 0.240 |
Why?
|
| Histone Deacetylases | 1 | 2004 | 52 | 0.240 |
Why?
|
| Nicardipine | 1 | 2023 | 7 | 0.240 |
Why?
|
| Cell Proliferation | 5 | 2019 | 1149 | 0.230 |
Why?
|
| Sequence Analysis, DNA | 2 | 2010 | 455 | 0.230 |
Why?
|
| Protein Transport | 1 | 2004 | 286 | 0.230 |
Why?
|
| Humans | 31 | 2023 | 34853 | 0.230 |
Why?
|
| Animals | 18 | 2023 | 14307 | 0.230 |
Why?
|
| Caenorhabditis elegans | 2 | 2002 | 74 | 0.220 |
Why?
|
| Eukaryotic Cells | 1 | 2002 | 32 | 0.220 |
Why?
|
| Membrane Proteins | 2 | 2016 | 486 | 0.220 |
Why?
|
| Software | 1 | 2004 | 204 | 0.220 |
Why?
|
| Internet | 1 | 2004 | 204 | 0.210 |
Why?
|
| Cell Cycle | 4 | 2019 | 309 | 0.210 |
Why?
|
| Cathepsin L | 2 | 2019 | 13 | 0.210 |
Why?
|
| Molecular Sequence Data | 7 | 2009 | 1490 | 0.210 |
Why?
|
| Adenocarcinoma | 2 | 2014 | 239 | 0.210 |
Why?
|
| Euchromatin | 1 | 2001 | 6 | 0.210 |
Why?
|
| Genome, Human | 3 | 2011 | 112 | 0.200 |
Why?
|
| Amino Acid Sequence | 5 | 2004 | 1124 | 0.190 |
Why?
|
| Systems Biology | 2 | 2011 | 20 | 0.190 |
Why?
|
| Retroviridae | 1 | 1999 | 22 | 0.180 |
Why?
|
| CCAAT-Binding Factor | 1 | 2019 | 2 | 0.180 |
Why?
|
| Neoplasm Proteins | 2 | 2016 | 203 | 0.180 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 3 | 2007 | 30 | 0.170 |
Why?
|
| Peroxidase | 1 | 2019 | 50 | 0.170 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2019 | 24 | 0.170 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2019 | 68 | 0.170 |
Why?
|
| Vitis | 1 | 2019 | 29 | 0.170 |
Why?
|
| Neoplasms, Glandular and Epithelial | 2 | 2016 | 40 | 0.170 |
Why?
|
| Estrogen Receptor alpha | 1 | 2019 | 105 | 0.170 |
Why?
|
| Homeodomain Proteins | 1 | 2019 | 128 | 0.160 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2017 | 184 | 0.160 |
Why?
|
| Centrosome | 2 | 2015 | 28 | 0.160 |
Why?
|
| DNA Methylation | 3 | 2007 | 301 | 0.160 |
Why?
|
| Genitalia | 1 | 2017 | 17 | 0.150 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2017 | 33 | 0.150 |
Why?
|
| Transfection | 3 | 2015 | 496 | 0.150 |
Why?
|
| Chlamydia trachomatis | 1 | 2017 | 66 | 0.150 |
Why?
|
| Female | 15 | 2018 | 19873 | 0.150 |
Why?
|
| Dendritic Cells | 1 | 2017 | 112 | 0.140 |
Why?
|
| Endogenous Retroviruses | 2 | 2006 | 16 | 0.140 |
Why?
|
| Gene Regulatory Networks | 3 | 2016 | 115 | 0.140 |
Why?
|
| Plant Extracts | 1 | 2019 | 250 | 0.140 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2016 | 58 | 0.140 |
Why?
|
| Chlamydia Infections | 1 | 2017 | 196 | 0.130 |
Why?
|
| Signal Transduction | 5 | 2019 | 1802 | 0.120 |
Why?
|
| Inhibitor of Differentiation Proteins | 1 | 2014 | 28 | 0.120 |
Why?
|
| Nerve Tissue Proteins | 1 | 2016 | 338 | 0.120 |
Why?
|
| Oxidative Stress | 1 | 2019 | 874 | 0.120 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2004 | 249 | 0.120 |
Why?
|
| Testosterone | 1 | 2014 | 181 | 0.120 |
Why?
|
| Drosophila | 2 | 2008 | 133 | 0.110 |
Why?
|
| Up-Regulation | 4 | 2017 | 490 | 0.110 |
Why?
|
| Gene Expression | 2 | 2014 | 639 | 0.110 |
Why?
|
| Sound | 1 | 2012 | 6 | 0.110 |
Why?
|
| Lung Neoplasms | 1 | 2016 | 336 | 0.100 |
Why?
|
| Histones | 3 | 2011 | 177 | 0.100 |
Why?
|
| Cell Separation | 1 | 2011 | 91 | 0.100 |
Why?
|
| Apoptosis | 4 | 2023 | 1317 | 0.100 |
Why?
|
| Green Fluorescent Proteins | 1 | 2012 | 200 | 0.100 |
Why?
|
| Phenotype | 2 | 2011 | 650 | 0.100 |
Why?
|
| Sulfoglycosphingolipids | 1 | 2010 | 1 | 0.100 |
Why?
|
| Adenocarcinoma, Papillary | 1 | 2009 | 3 | 0.090 |
Why?
|
| Frozen Sections | 1 | 2009 | 7 | 0.090 |
Why?
|
| Microdissection | 1 | 2009 | 11 | 0.090 |
Why?
|
| Adult Stem Cells | 1 | 2009 | 12 | 0.090 |
Why?
|
| Lasers | 1 | 2009 | 62 | 0.090 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2009 | 10 | 0.090 |
Why?
|
| Cell Differentiation | 2 | 2011 | 562 | 0.090 |
Why?
|
| Ovarian Diseases | 1 | 2008 | 3 | 0.090 |
Why?
|
| Mice | 5 | 2023 | 5668 | 0.090 |
Why?
|
| Mass Spectrometry | 1 | 2010 | 255 | 0.090 |
Why?
|
| Microspheres | 1 | 2009 | 45 | 0.090 |
Why?
|
| Lipids | 1 | 2010 | 222 | 0.080 |
Why?
|
| DNA | 1 | 2012 | 549 | 0.080 |
Why?
|
| Leukemia, T-Cell | 1 | 2008 | 5 | 0.080 |
Why?
|
| Dosage Compensation, Genetic | 1 | 2008 | 7 | 0.080 |
Why?
|
| Embryonic Stem Cells | 1 | 2009 | 57 | 0.080 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2009 | 166 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2007 | 605 | 0.080 |
Why?
|
| Breast Neoplasms | 2 | 2018 | 1426 | 0.080 |
Why?
|
| Recombination, Genetic | 2 | 2010 | 90 | 0.080 |
Why?
|
| Carcinoma | 1 | 2008 | 94 | 0.080 |
Why?
|
| Cluster Analysis | 3 | 2014 | 188 | 0.080 |
Why?
|
| Sequence Alignment | 2 | 2009 | 257 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2016 | 298 | 0.080 |
Why?
|
| Cell Survival | 3 | 2019 | 818 | 0.080 |
Why?
|
| Genes, p53 | 1 | 2007 | 24 | 0.080 |
Why?
|
| Genes, Neoplasm | 1 | 2007 | 14 | 0.080 |
Why?
|
| Male | 7 | 2023 | 18870 | 0.070 |
Why?
|
| Multigene Family | 2 | 2010 | 105 | 0.070 |
Why?
|
| MicroRNAs | 1 | 2011 | 386 | 0.070 |
Why?
|
| Pan troglodytes | 1 | 2006 | 21 | 0.070 |
Why?
|
| RNA, Small Interfering | 2 | 2019 | 391 | 0.070 |
Why?
|
| Proteomics | 2 | 2019 | 302 | 0.070 |
Why?
|
| Chromosome Mapping | 2 | 2003 | 159 | 0.070 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2004 | 6 | 0.060 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2004 | 1 | 0.060 |
Why?
|
| Genes, Insect | 1 | 2004 | 20 | 0.060 |
Why?
|
| Genomics | 1 | 2006 | 201 | 0.060 |
Why?
|
| Mice, Nude | 2 | 2016 | 323 | 0.060 |
Why?
|
| Immunohistochemistry | 1 | 2006 | 859 | 0.060 |
Why?
|
| Sexual Behavior, Animal | 1 | 2004 | 51 | 0.060 |
Why?
|
| Conserved Sequence | 1 | 2004 | 106 | 0.060 |
Why?
|
| Databases, Nucleic Acid | 1 | 2004 | 25 | 0.060 |
Why?
|
| Antineoplastic Agents | 2 | 2011 | 756 | 0.060 |
Why?
|
| Macromolecular Substances | 1 | 2004 | 86 | 0.060 |
Why?
|
| Amino Acid Substitution | 1 | 2004 | 122 | 0.060 |
Why?
|
| Models, Genetic | 2 | 2006 | 149 | 0.060 |
Why?
|
| Chromosomes, Fungal | 1 | 2003 | 3 | 0.060 |
Why?
|
| Protein Isoforms | 1 | 2004 | 121 | 0.060 |
Why?
|
| Mutagenesis, Insertional | 1 | 2003 | 32 | 0.060 |
Why?
|
| Autoantigens | 1 | 2004 | 82 | 0.060 |
Why?
|
| Gene Expression Regulation | 3 | 2009 | 968 | 0.060 |
Why?
|
| Alleles | 1 | 2004 | 284 | 0.060 |
Why?
|
| Trans-Activators | 1 | 2004 | 167 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 1 | 2004 | 383 | 0.060 |
Why?
|
| Ribonuclease H | 1 | 2002 | 11 | 0.060 |
Why?
|
| Genes | 1 | 2002 | 58 | 0.060 |
Why?
|
| DNA, Intergenic | 1 | 2002 | 10 | 0.060 |
Why?
|
| Cell Movement | 2 | 2019 | 545 | 0.050 |
Why?
|
| Drosophila Proteins | 1 | 2004 | 162 | 0.050 |
Why?
|
| Immune System | 1 | 2002 | 40 | 0.050 |
Why?
|
| Reproduction | 1 | 2002 | 63 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 2004 | 287 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 2 | 2017 | 1530 | 0.050 |
Why?
|
| Neoplasm Staging | 2 | 2014 | 269 | 0.050 |
Why?
|
| Cell Nucleus | 1 | 2002 | 351 | 0.050 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 1999 | 17 | 0.050 |
Why?
|
| Gene Products, env | 1 | 1999 | 23 | 0.050 |
Why?
|
| Disease Progression | 2 | 2015 | 580 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2017 | 1442 | 0.040 |
Why?
|
| Gluconeogenesis | 1 | 2019 | 10 | 0.040 |
Why?
|
| Middle Aged | 4 | 2018 | 9642 | 0.040 |
Why?
|
| Aged | 3 | 2018 | 6448 | 0.040 |
Why?
|
| Prognosis | 2 | 2014 | 707 | 0.040 |
Why?
|
| Microarray Analysis | 1 | 2019 | 61 | 0.040 |
Why?
|
| Metabolomics | 1 | 2019 | 76 | 0.040 |
Why?
|
| Cadherins | 1 | 2018 | 82 | 0.040 |
Why?
|
| Antimetabolites, Antineoplastic | 2 | 2008 | 18 | 0.040 |
Why?
|
| Base Sequence | 3 | 2009 | 932 | 0.040 |
Why?
|
| Cell Line | 2 | 2011 | 1289 | 0.040 |
Why?
|
| Pyruvic Acid | 1 | 2017 | 16 | 0.040 |
Why?
|
| Epigenesis, Genetic | 2 | 2011 | 198 | 0.040 |
Why?
|
| Breast | 1 | 2018 | 134 | 0.040 |
Why?
|
| Prostate | 1 | 2018 | 136 | 0.040 |
Why?
|
| Cell Membrane Permeability | 1 | 2017 | 49 | 0.040 |
Why?
|
| Antigen Presentation | 1 | 2017 | 54 | 0.040 |
Why?
|
| Interleukin-10 | 1 | 2017 | 69 | 0.040 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1997 | 60 | 0.040 |
Why?
|
| Immunity, Innate | 1 | 2017 | 135 | 0.040 |
Why?
|
| Receptor, erbB-3 | 1 | 2016 | 11 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 2019 | 550 | 0.040 |
Why?
|
| Adult | 3 | 2018 | 11034 | 0.030 |
Why?
|
| Aneuploidy | 1 | 2015 | 20 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2016 | 242 | 0.030 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2015 | 32 | 0.030 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2015 | 25 | 0.030 |
Why?
|
| Receptor, erbB-2 | 1 | 2016 | 122 | 0.030 |
Why?
|
| Genetic Loci | 1 | 2015 | 70 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2016 | 183 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2014 | 114 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2017 | 897 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2014 | 114 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2014 | 79 | 0.030 |
Why?
|
| Microtubules | 1 | 2015 | 113 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2016 | 420 | 0.030 |
Why?
|
| Protein Interaction Mapping | 1 | 2014 | 57 | 0.030 |
Why?
|
| Hela Cells | 1 | 2015 | 344 | 0.030 |
Why?
|
| Receptors, Androgen | 1 | 2015 | 122 | 0.030 |
Why?
|
| Mitochondria | 1 | 2017 | 454 | 0.030 |
Why?
|
| Mitosis | 1 | 2014 | 97 | 0.030 |
Why?
|
| Lung | 1 | 2016 | 413 | 0.030 |
Why?
|
| Neoplasms | 1 | 2002 | 1033 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 2333 | 0.030 |
Why?
|
| Ultrasonic Therapy | 1 | 2012 | 5 | 0.030 |
Why?
|
| DNA Topoisomerases, Type II | 1 | 2012 | 10 | 0.030 |
Why?
|
| Methods | 1 | 2011 | 12 | 0.030 |
Why?
|
| Erythroid Precursor Cells | 1 | 2011 | 6 | 0.030 |
Why?
|
| K562 Cells | 1 | 2011 | 31 | 0.030 |
Why?
|
| Spheroids, Cellular | 1 | 2011 | 28 | 0.030 |
Why?
|
| Antigens, Neoplasm | 1 | 2012 | 56 | 0.030 |
Why?
|
| Plasmids | 1 | 2012 | 233 | 0.020 |
Why?
|
| Age Factors | 1 | 2014 | 1007 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2016 | 1300 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2011 | 247 | 0.020 |
Why?
|
| Pharmaceutical Preparations | 1 | 2012 | 74 | 0.020 |
Why?
|
| DNA, Plant | 1 | 2010 | 13 | 0.020 |
Why?
|
| Genome, Plant | 1 | 2010 | 26 | 0.020 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2011 | 209 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2012 | 287 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2012 | 220 | 0.020 |
Why?
|
| Burkitt Lymphoma | 1 | 2009 | 23 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2011 | 271 | 0.020 |
Why?
|
| Tissue Array Analysis | 1 | 2008 | 65 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2009 | 138 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2011 | 984 | 0.020 |
Why?
|
| Tretinoin | 1 | 2009 | 50 | 0.020 |
Why?
|
| Jurkat Cells | 1 | 2008 | 72 | 0.020 |
Why?
|
| Histone Acetyltransferases | 1 | 2008 | 18 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2008 | 211 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2009 | 171 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2008 | 71 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2008 | 93 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2008 | 322 | 0.020 |
Why?
|
| Binding Sites | 1 | 2009 | 597 | 0.020 |
Why?
|
| Loss of Heterozygosity | 1 | 2007 | 18 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2008 | 160 | 0.020 |
Why?
|
| Azacitidine | 1 | 2007 | 21 | 0.020 |
Why?
|
| Drug Design | 1 | 2008 | 154 | 0.020 |
Why?
|
| CpG Islands | 1 | 2007 | 91 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2011 | 1152 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2008 | 964 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2007 | 210 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2008 | 901 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2008 | 1422 | 0.020 |
Why?
|
| Genetic Complementation Test | 1 | 2002 | 56 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2002 | 84 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2008 | 1961 | 0.010 |
Why?
|
| Databases, Genetic | 1 | 2002 | 90 | 0.010 |
Why?
|
| Genetic Code | 1 | 1997 | 7 | 0.010 |
Why?
|